News | September 25, 2022
Aptar Pharma collaborates with Fluidda
The companies will leverage their respective proprietary technology platforms
The companies will leverage their respective proprietary technology platforms
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
To set up 50 lifestyle modification centres across the UAE in the next 24 months
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Lenalidomide is used to treat various types of cancers.
The ANDA was filed as 'First to File' submission on NCE-1 date.
Subscribe To Our Newsletter & Stay Updated
